Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 7, 2007

Correlogic Systems and JEOL Sign R&D Agreement for Clinical Application of Mass Spec

  • Correlogic Systems and JEOL signed a research and development agreement focused on further enhancing the performance of mass spectrometry in a clinical setting. Correlogic and JEOL have collaborated for more than a year under an informal agreement and have made great strides in the continuing validation of various mass spectrometer-based assays, according to the companies.

    “Over the past year, we have had a very close and productive research collaboration with JEOL,” said Peter J. Levine, president and CEO of Correlogic Systems. “This agreement formalizes our link.”



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »